Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPalace Capital Regulatory News (PCA)

Share Price Information for Palace Capital (PCA)

Share Price is delayed by 15 minutes
Get Live Data
165.00    2.00 (1.23%)
Bid:
165.00
Ask:
167.00
Spread: 2.00 (1.212%)
Market Cap: £32.22m
PCA Live PriceLast checked at - London Stock Exchange

Intraday Palace Capital Share Chart

Director Dealing

24 Jul 2019 17:47

RNS Number : 6350G
Palace Capital PLC
24 July 2019
 

24 July 2019

 

 

Palace Capital PLC

("Palace Capital", the "Company" or the "Group")

 

Director Dealing

 

Palace Capital, the property investment company that focusses on commercial property outside London, announces the following transactions by certain Directors and PDMRs of the Company pursuant to the awards granted on 13 July 2018 under the Palace Capital Deferred Bonus Plan (2018 DBP) and 4 July 2016 under the Palace Capital Long Term Incentive Plan (2016 LTIP).

 

DBP

On 13 July 2019 the awards granted under the 2018 DBP became exercisable following satisfaction of the one-year service period. In accordance with the rules of the plan, as part of the exercise additional shares were added to each award, equivalent to the dividends payable during the service period.

 

LTIP

On 4 July 2019 50% of the awards granted under the 2016 LTIP became exercisable following satisfaction of the performance conditions (relating to Net Asset Growth and Total Shareholder Return).

 

Exercise

On 23 July 2019 Directors and PDMRs exercised their awards. Some sold all the shares awarded to them, others sold sufficient Shares to meet income tax and national insurance liabilities, retaining the balance, and in the case of Neil Sinclair, selling additional shares to fund tax liabilities. Awards were satisfied using shares from the Palace Capital PLC Employee Benefit Trust. As part of this transaction 150,000 shares were transferred from Treasury to the EBT to settle the awards.

 

Directors shareholdings

 

Following these transactions, the Director's and PDMR's, including persons closely associated with them, have the following interests in the Ordinary Shares of 10 pence of the Company:

 

Director/PDMR

Shares held prior to the transactions

Share options exercised

No. of shares sold

Total Palace shares held

% of Palace shares in issue

Neil Sinclair

229,279

66,211

52,424

243,066

0.52%

Richard Starr

149,921

42,797

20,115

172,603

0.37%

Stephen Silvester

12,184

33,373

15,686

29,871

0.06%

David Kaye

-

5,340

5,340

-

0%

Matthew Simpson

-

5,538

2,326

3,212

0.01%

 

 

Total Voting Rights

The Company's issued and outstanding share capital is 46,388,515 of which 299,587 Ordinary Shares are held in treasury. The net figure of 46,088,928 Ordinary Shares may be used as the denominator for shareholder calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

 

For further information, contact:

PALACE CAPITAL PLC

Neil Sinclair, Chief Executive Stephen Silvester, Finance DirectorTel. +44 (0)20 3301 8331

 

Broker

Numis Securities

Heraclis Economides / Oliver Hardy

Tel: +44 (0)20 7260 1000

 

Broker

Arden Partners plc

Corporate Finance: Paul Shackleton / Ciaran Walsh / Daniel Gee-Summons

Corporate Broking: James Reed-Daunter

Tel: +44 (0)207 614 5900

 

Financial PR 

FTI Consulting

Claire Turvey / Methuselah Tanyanyiwa

Tel: +44 (0)20 3727 1000

palacecapital@fticonsulting.com

 

About Palace Capital plc (www.palacecapitalplc.com)

 

Palace Capital is a property investment company with a premium listing on the Main Market of the London Stock Exchange (Stock Code: PCA). The Company owns a diversified regional portfolio across the UK and has a reputation for being entrepreneurial and opportunistic. Palace Capital acquires properties where it can enhance the long-term income and capital value through asset management and strategic capital development in locations outside London.

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

a. Neil Sinclair (Chief Executive)

b. Richard Starr (Executive Director)

c. Stephen Silvester (Finance Director)

d. David Kaye (Company Secretary)

e. Matthew Simpson (Financial Controller)

2

Reason for the notification

a)

Position/status

See 1 a) above

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Palace Capital plc

b)

LEI

2138009JDFQOXJFCJQ05

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 Identification code

Exercise of option over Ordinary shares of 10p

 

Identification code (ISIN) for Palace Capital plc ordinary shares: GB00BF5SGF06

b)

Nature of the transaction

Exercise of options

c)

Price(s) and volume(s)

 Price: nil

a. 66,211

b. 42,797

c. 33,373

d. 5,340

e. 5,538

 

d)

Aggregated information

- Aggregated volume

- Price

 

153,259

Nil

e)

Date of the transaction

23 July 2019

f)

Place of the transaction

Outside a trading venue

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

a. Neil Sinclair (Chief Executive)

b. Richard Starr (Executive Director)

c. Stephen Silvester (Finance Director)

d. David Kaye (Company Secretary)

e. Matthew Simpson (Financial Controller)

2

Reason for the notification

a)

Position/status

See 1 a) above

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Palace Capital plc

b)

LEI

2138009JDFQOXJFCJQ05

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 Identification code

Sale of Ordinary shares of 10p

 

Identification code (ISIN) for Palace Capital plc ordinary shares: GB00BF5SGF06

b)

Nature of the transaction

Sale of Shares

c)

Price(s) and volume(s)

 Price: 276p

a. 52,424

b. 20,115

c. 15,686

d. 5,340

e. 2,326

 

d)

Aggregated information

- Aggregated volume

- Price

 

95,891

276p

e)

Date of the transaction

23 July 2019

f)

Place of the transaction

London Stock Exchange, (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHLLFSRDEISFIA
Date   Source Headline
26th Nov 20208:00 amEQSPalace Capital (PCA): COVID-19 impacts actively managed
24th Nov 20205:20 pmEQSHardman & Co Research: Palace Capital (PCA): Interim results on track - upside clear in FY'22
17th Nov 20207:00 amRNSHalf-year Report
13th Nov 20207:00 amRNSInvestor Presentation
26th Oct 20203:00 pmRNSDirector/PDMR Shareholding
16th Oct 20202:09 pmRNSDirector Dealing
13th Oct 20207:00 amRNSUpdate on trading and rent collection
7th Oct 20203:40 pmRNSHolding(s) in Company
7th Oct 20207:00 amRNSHolding(s) in Company
2nd Oct 20207:00 amRNSHolding(s) in Company
2nd Oct 20207:00 amRNSReduction of Share Premium Account
15th Sep 20207:00 amRNSDividend Declaration
4th Sep 20202:00 pmEQSHardman & Co Research: Hardman Talks: Palace Capital interview with Mike Foster
7th Aug 20201:40 pmRNSResult of AGM
15th Jul 20201:55 pmRNSNotice of AGM
15th Jul 20207:00 amRNSGrant of awards under Deferred Bonus Plan
14th Jul 20203:05 pmEQSHardman & Co Research: Palace Capital (PCA): Encouraging full-year results
13th Jul 20207:00 amRNSDirector/PDMR Shareholding
9th Jul 20203:28 pmRNSDirector/PDMR Dealing
7th Jul 20202:52 pmRNSFinal Results for the year ended 31 March 2020
7th Jul 20207:00 amRNSFinal Results for the year ended 31 March 2020
3rd Jul 20205:03 pmRNSHolding(s) in Company
3rd Jul 20202:40 pmRNSNotice of Results & Investor Presentation
17th Jun 20205:45 pmEQSCORRECTION: Hardman & Co Research: Palace Capital presenting at virtual Investor Forum on 9th July 2020
17th Jun 20209:27 amEQSHardman & Co Research: Palace Capital presenting at virtual Investor Forum on 9th July 2020
27th Apr 20202:33 pmRNSDirector Dealing
27th Apr 202012:08 pmRNSSecond Price Monitoring Extn
27th Apr 202012:02 pmRNSPrice Monitoring Extension
17th Apr 20207:00 amRNSInvestor presentation
7th Apr 20204:36 pmRNSPrice Monitoring Extension
6th Apr 20203:20 pmEQSHardman & Co Research: Palace Capital (PCA): Trading update and COVID-related dividend cut
2nd Apr 20207:00 amRNSCOVID-19 and dividend update
27th Mar 202010:09 amRNSDirector Dealing
10th Mar 20207:00 amRNSDividend Declaration
10th Feb 20204:40 pmRNSSecond Price Monitoring Extn
10th Feb 20204:35 pmRNSPrice Monitoring Extension
10th Feb 20207:00 amRNSRecord office rent in Hudson Quarter, York
3rd Feb 20207:00 amRNSAppointment of Non-Executive Director
27th Jan 202012:07 pmRNSSecond Price Monitoring Extn
27th Jan 202012:02 pmRNSPrice Monitoring Extension
8th Jan 202011:48 amRNSDirector dealing
12th Dec 201912:07 pmRNSSecond Price Monitoring Extn
12th Dec 201912:02 pmRNSPrice Monitoring Extension
9th Dec 20197:00 amRNSPALACE CAPITAL DISPOSES OF BIRMINGHAM ASSET
27th Nov 20193:35 pmEQSHardman & Co Research: Palace Capital (PCA): 1H'20 results announced
19th Nov 20197:00 amRNSHalf-year Report
24th Oct 20197:00 amRNS17 Lease Renewals and Rent Reviews
23rd Oct 201910:30 amRNSNotice of Interim Results
18th Oct 20193:56 pmRNSDirector dealing
15th Oct 20195:07 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.